Avalo Therapeutics Inc (AVTX) — Free Cash Flow Generation Index
Avalo Therapeutics Inc (AVTX) has a Free Cash Flow Generation Index of 0.99x as of September 2022. Free cash flow of $5.69 Million represents 1% of operating cash flow ($5.73 Million). Explore Avalo Therapeutics Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Avalo Therapeutics Inc Free Cash Flow Generation Index (2017–2017)
Historical FCF Generation Index trend for Avalo Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see AVTX cash generation efficiency.
Annual Free Cash Flow Generation for Avalo Therapeutics Inc (2017–2017)
Year-by-year Free Cash Flow Generation Index for Avalo Therapeutics Inc. Check Avalo Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2017 | 1.00x | $12.50 Million | $12.52 Million | $23.32K | — |